Walleye Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-463,376
Closed -$8.36M 5144
2025
Q3
$5.63M Sell
463,376
-103,847
-18% -$1.41M 0.02% 857
2025
Q2
$10.6M Buy
+567,223
New +$11.2M 0.04% 477
2025
Q1
Sell
-2,098
Closed -$75.6K 5130
2024
Q4
$75.6K Buy
2,098
+1,279
+156% +$43.3K ﹤0.01% 4239
2024
Q3
$34.7K Sell
819
-55,015
-99% -$2.33M ﹤0.01% 4714
2024
Q2
$2.25M Buy
55,834
+50,813
+1,012% +$2.12M ﹤0.01% 1992
2024
Q1
$178K Buy
+5,021
New +$135K ﹤0.01% 4054
2023
Q3
Sell
-215,299
Closed -$5.91M 5330
2023
Q2
$5.28M Buy
215,299
+161,961
+304% +$5.21M 0.02% 697
2023
Q1
$2.17M Buy
53,338
+35,861
+205% +$1.48M 0.03% 673
2022
Q4
$786K Buy
17,477
+8,648
+98% +$391K 0.01% 1145
2022
Q3
$422K Sell
8,829
-11,787
-57% -$646K 0.01% 1580
2022
Q2
$1.22M Buy
20,616
+8,071
+64% +$663K 0.03% 555
2022
Q1
$1.46M Buy
12,545
+6,566
+110% +$767K 0.04% 467
2021
Q4
$900K Sell
5,979
-2,268
-28% -$306K 0.03% 656
2021
Q3
$985 Buy
+8,247
New +$909K 0.03% 449
2019
Q2
Sell
-60
Closed -$3.87K 2038
2019
Q1
$4K Buy
+60
New +$3.15K ﹤0.01% 1451

Other funds holding TNDM

Walleye Capital's TNDM Position: Q4 2025 in Review

Walleye Capital sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 463,376 shares — an estimated $8.36M sold.

Walleye Capital first reported a position in TNDM in Q1 2019 and held it in 15 quarters. The position peaked at $10.6M in Q2 2025. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Walleye Capital reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 463,376 Tandem Diabetes Care shares in Q4 2025, an estimated $8.36M.
  • Walleye Capital first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 15 quarters.
  • Walleye Capital's Tandem Diabetes Care position peaked at $10.6M in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.